
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
MYBL1 rearrangements and MYB amplification in breast adenoid cystic carcinomas lacking the MYB–NFIB fusion gene
Jisun Kim, Felipe C. Geyer, Luciano G. Martelotto, et al.
The Journal of Pathology (2017) Vol. 244, Iss. 2, pp. 143-150
Open Access | Times Cited: 82
Jisun Kim, Felipe C. Geyer, Luciano G. Martelotto, et al.
The Journal of Pathology (2017) Vol. 244, Iss. 2, pp. 143-150
Open Access | Times Cited: 82
Showing 1-25 of 82 citing articles:
Pathogenesis of Triple-Negative Breast Cancer
Fatemeh Derakhshan, Jorge S. Reis‐Filho
Annual Review of Pathology Mechanisms of Disease (2022) Vol. 17, Iss. 1, pp. 181-204
Open Access | Times Cited: 363
Fatemeh Derakhshan, Jorge S. Reis‐Filho
Annual Review of Pathology Mechanisms of Disease (2022) Vol. 17, Iss. 1, pp. 181-204
Open Access | Times Cited: 363
MYB oncoproteins: emerging players and potential therapeutic targets in human cancer
Ylenia Cicirò, Arturo Sala
Oncogenesis (2021) Vol. 10, Iss. 2
Open Access | Times Cited: 133
Ylenia Cicirò, Arturo Sala
Oncogenesis (2021) Vol. 10, Iss. 2
Open Access | Times Cited: 133
Loss-of-function mutations in ATP6AP1 and ATP6AP2 in granular cell tumors
Fresia Pareja, Alissa Brandes, Thais Basili, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 121
Fresia Pareja, Alissa Brandes, Thais Basili, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 121
Triple-Negative Breast Cancer Histological Subtypes with a Favourable Prognosis
Gábor Cserni, Cecily Quinn, Maria Pia Foschini, et al.
Cancers (2021) Vol. 13, Iss. 22, pp. 5694-5694
Open Access | Times Cited: 71
Gábor Cserni, Cecily Quinn, Maria Pia Foschini, et al.
Cancers (2021) Vol. 13, Iss. 22, pp. 5694-5694
Open Access | Times Cited: 71
Recent Advances on Immunohistochemistry and Molecular Biology for the Diagnosis of Adnexal Sweat Gland Tumors
Nicolas Macagno, Pierre Sohier, Thibault Kervarrec, et al.
Cancers (2022) Vol. 14, Iss. 3, pp. 476-476
Open Access | Times Cited: 43
Nicolas Macagno, Pierre Sohier, Thibault Kervarrec, et al.
Cancers (2022) Vol. 14, Iss. 3, pp. 476-476
Open Access | Times Cited: 43
Molecular Classification of Breast Cancer
Madhuchhanda Roy, Amy M. Fowler, Gary A. Ulaner, et al.
PET Clinics (2023) Vol. 18, Iss. 4, pp. 441-458
Closed Access | Times Cited: 38
Madhuchhanda Roy, Amy M. Fowler, Gary A. Ulaner, et al.
PET Clinics (2023) Vol. 18, Iss. 4, pp. 441-458
Closed Access | Times Cited: 38
Molecular Basis of Breast Tumor Heterogeneity
Esra Dikoglu, Fresia Pareja
Advances in experimental medicine and biology (2025), pp. 237-257
Closed Access | Times Cited: 1
Esra Dikoglu, Fresia Pareja
Advances in experimental medicine and biology (2025), pp. 237-257
Closed Access | Times Cited: 1
New Advances in Molecular Breast Cancer Pathology
Emad A. Rakha, Fresia Pareja
Seminars in Cancer Biology (2020) Vol. 72, pp. 102-113
Closed Access | Times Cited: 69
Emad A. Rakha, Fresia Pareja
Seminars in Cancer Biology (2020) Vol. 72, pp. 102-113
Closed Access | Times Cited: 69
Novel uses of immunohistochemistry in breast pathology: interpretation and pitfalls
Ashley Cimino‐Mathews
Modern Pathology (2020) Vol. 34, pp. 62-77
Open Access | Times Cited: 58
Ashley Cimino‐Mathews
Modern Pathology (2020) Vol. 34, pp. 62-77
Open Access | Times Cited: 58
MYBL2 amplification in breast cancer: Molecular mechanisms and therapeutic potential
Rachel Bayley, Ciara Ward, Paloma García
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2020) Vol. 1874, Iss. 2, pp. 188407-188407
Closed Access | Times Cited: 50
Rachel Bayley, Ciara Ward, Paloma García
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2020) Vol. 1874, Iss. 2, pp. 188407-188407
Closed Access | Times Cited: 50
Rare subtypes of triple negative breast cancer: Current understanding and future directions
Alexandra Thomas, Jorge S. Reis‐Filho, Charles E. Geyer, et al.
npj Breast Cancer (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 20
Alexandra Thomas, Jorge S. Reis‐Filho, Charles E. Geyer, et al.
npj Breast Cancer (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 20
Solid-type adenoid cystic carcinoma of the breast, a distinct molecular entity enriched in NOTCH and CREBBP mutations
Julie Massé, Caroline Truntzer, Romain Boidot, et al.
Modern Pathology (2019) Vol. 33, Iss. 6, pp. 1041-1055
Open Access | Times Cited: 53
Julie Massé, Caroline Truntzer, Romain Boidot, et al.
Modern Pathology (2019) Vol. 33, Iss. 6, pp. 1041-1055
Open Access | Times Cited: 53
Identification of recurrent FHL2-GLI2 oncogenic fusion in sclerosing stromal tumors of the ovary
Sarah H. Kim, Arnaud Da Cruz Paula, Thais Basili, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 44
Sarah H. Kim, Arnaud Da Cruz Paula, Thais Basili, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 44
The clinical behavior and genomic features of the so-called adenoid cystic carcinomas of the solid variant with basaloid features
Christopher J. Schwartz, Edi Brogi, Antonio Marra, et al.
Modern Pathology (2021) Vol. 35, Iss. 2, pp. 193-201
Open Access | Times Cited: 39
Christopher J. Schwartz, Edi Brogi, Antonio Marra, et al.
Modern Pathology (2021) Vol. 35, Iss. 2, pp. 193-201
Open Access | Times Cited: 39
Low-risk triple-negative breast cancers: Clinico-pathological and molecular features
Nicola Fusco, Elham Sajjadi, Konstantinos Venetis, et al.
Critical Reviews in Oncology/Hematology (2022) Vol. 172, pp. 103643-103643
Closed Access | Times Cited: 28
Nicola Fusco, Elham Sajjadi, Konstantinos Venetis, et al.
Critical Reviews in Oncology/Hematology (2022) Vol. 172, pp. 103643-103643
Closed Access | Times Cited: 28
Update on triple‐negative breast cancers – highlighting subtyping update and treatment implication
Julia Y. Tsang, Gary M. Tse
Histopathology (2022) Vol. 82, Iss. 1, pp. 17-35
Closed Access | Times Cited: 26
Julia Y. Tsang, Gary M. Tse
Histopathology (2022) Vol. 82, Iss. 1, pp. 17-35
Closed Access | Times Cited: 26
Adenoid Cystic Carcinoma from the salivary and lacrimal glands and the breast: Different clinical outcomes to the same tumor
Carolina Emerick, Fernanda Viviane Mariano, Pablo Agustín Vargas, et al.
Critical Reviews in Oncology/Hematology (2022) Vol. 179, pp. 103792-103792
Closed Access | Times Cited: 25
Carolina Emerick, Fernanda Viviane Mariano, Pablo Agustín Vargas, et al.
Critical Reviews in Oncology/Hematology (2022) Vol. 179, pp. 103792-103792
Closed Access | Times Cited: 25
A Human Breast Cell Atlas Mapping the Homeostatic Cellular Shifts in the Adult Breast
Austin D. Reed, Sara Pensa, Adi Steif, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 13
Austin D. Reed, Sara Pensa, Adi Steif, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 13
Triple-negative breast cancer: from none to multiple therapeutic targets in two decades
Filomena Marino Carvalho
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 13
Filomena Marino Carvalho
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 13
Predictors of Outcome in Mammary Adenoid Cystic Carcinoma
Elzbieta Slodkowska, Bin Xu, Zuzana Kos, et al.
The American Journal of Surgical Pathology (2019) Vol. 44, Iss. 2, pp. 214-223
Closed Access | Times Cited: 38
Elzbieta Slodkowska, Bin Xu, Zuzana Kos, et al.
The American Journal of Surgical Pathology (2019) Vol. 44, Iss. 2, pp. 214-223
Closed Access | Times Cited: 38
The genomic landscape of metastatic histologic special types of invasive breast cancer
Fresia Pareja, Lorenzo Ferrando, Simon S. K. Lee, et al.
npj Breast Cancer (2020) Vol. 6, Iss. 1
Open Access | Times Cited: 35
Fresia Pareja, Lorenzo Ferrando, Simon S. K. Lee, et al.
npj Breast Cancer (2020) Vol. 6, Iss. 1
Open Access | Times Cited: 35
PTEN Expression as a Complementary Biomarker for Mismatch Repair Testing in Breast Cancer
Gianluca Lopez, Marianna Noale, Chiara Corti, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 4, pp. 1461-1461
Open Access | Times Cited: 34
Gianluca Lopez, Marianna Noale, Chiara Corti, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 4, pp. 1461-1461
Open Access | Times Cited: 34
Pleomorphic adenomas and mucoepidermoid carcinomas of the breast are underpinned by fusion genes
Fresia Pareja, Arnaud Da Cruz Paula, Rodrigo Gularte‐Mérida, et al.
npj Breast Cancer (2020) Vol. 6, Iss. 1
Open Access | Times Cited: 34
Fresia Pareja, Arnaud Da Cruz Paula, Rodrigo Gularte‐Mérida, et al.
npj Breast Cancer (2020) Vol. 6, Iss. 1
Open Access | Times Cited: 34
Problematic breast tumors reassessed in light of novel molecular data
Fresia Pareja, Britta Weigelt, Jorge S. Reis‐Filho
Modern Pathology (2020) Vol. 34, pp. 38-47
Open Access | Times Cited: 33
Fresia Pareja, Britta Weigelt, Jorge S. Reis‐Filho
Modern Pathology (2020) Vol. 34, pp. 38-47
Open Access | Times Cited: 33
Adenoid cystic carcinoma of the breast, from diagnosis to management: a case report
Mendoza-Urbano Diana Marcela, Diana Cañón, Palazuelos Gloria Ines, et al.
Journal of Medical Case Reports (2025) Vol. 19, Iss. 1
Open Access
Mendoza-Urbano Diana Marcela, Diana Cañón, Palazuelos Gloria Ines, et al.
Journal of Medical Case Reports (2025) Vol. 19, Iss. 1
Open Access